Myxoid pleomorphic liposarcoma is distinguished from other liposarcomas by widespread loss of heterozygosity and significantly worse overall survival: a genomic and clinicopathologic study
Josephine K. Dermawan, Sinchun Hwang, Leonard H. Wexler, William D. Tap, Samuel Singer, Chad Vanderbilt, Cristina R. Antonescu
Topics & Concepts
LiposarcomaBiologyPathologyLoss of heterozygosityMyxoid liposarcomaMediastinumSarcomaATRXMedicineAlleleAnatomyMutationGeneticsGeneSarcoma Diagnosis and TreatmentCardiac tumors and thrombiBone Tumor Diagnosis and Treatments